CureVac shares have been volatile over the past week, gaining some 25%. The stock has seen increased trading volume following ...

Shares of CureVac fell by 12.3% Wednesday afternoon. The pullback may stem from profit-taking after Tuesday's strong gains ...

Leerink Partners has recently reduced CureVac BV (CVAC) stock to Market Perform rating, as announced on April 25, 2024, according to Finviz. Earlier, on June 8, 2023, SVB Securities had initiated the ...

CureVac BV (CVAC) stock saw a modest uptick, ending the day at $4.44 which represents a slight increase of $0.82 or 22.65% from the prior close of $3.62. The stock opened at $4.14 and touched a low of ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

Schroon Lake overtook Chazy in the second half on Thursday night and recorded a hard-earned 44-38 victory in Mountain & ...

Jefferies sees Arbutus (ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE)/GSK ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Moriah connected on 14 three-pointers on Tuesday night and defeated Beekmantown, 66-59, in Champlain Valley Athletic ...

Saturday was a rivalry game and an early CVAC contest for Beekmantown and P. But, the night was bigger than just a game. It was Hannah’s Hope Night. Over the course of the night, the event raised ...

Shares of Moderna (MRNA), one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, were up nearly 10% in early trading ...

Investors are weighing Nvidia's big AI plans and puzzling over Trump's tariff policy in the wait for fresh jobs data.